Grown Rogue International (GRUSF) Non-Current Deffered Revenue (2017 - 2021)
Grown Rogue International (GRUSF) posted quarterly Non-Current Deffered Revenue of -$8347.3 for Q4 2021, down 179.54% year-over-year from $10494.0 in Q4 2020, and down 179.54% quarter-over-quarter from $10494.0 in Q4 2020.
Grown Rogue International (GRUSF) Non-Current Deffered Revenue (2017 - 2021) Analysis & Trends
Grown Rogue International's Non-Current Deffered Revenue history runs 5 years deep, the most recent figure standing at -$8347.3 for Q4 2021.
- In Q4 2021, Non-Current Deffered Revenue fell 179.54% year-over-year to -$8347.3; the TTM figure through Oct 2021 stood at -$8347.3 (down 179.54% YoY), while the FY2021 annual figure was -$8345.4, down 179.53% from the prior year.
- Non-Current Deffered Revenue for Q4 2021 stood at -$8347.3, down from $10494.0 in the prior quarter.
- The five-year high for Non-Current Deffered Revenue was $36881.0 in Q2 2018, with the low at -$8347.3 in Q4 2021.
- The 5-year median for Non-Current Deffered Revenue is $26475.0 (2019), against an average of $23701.9.
- The sharpest annual moves came in 2018 and 2021: Non-Current Deffered Revenue increased 25.47% in 2018, then plunged 179.54% in 2021.
- Grown Rogue International's Non-Current Deffered Revenue stood at $24912.0 in 2017, then rose by 25.47% to $31256.0 in 2018, then retreated by 21.6% to $24505.0 in 2019, then plunged by 57.18% to $10494.0 in 2020, then slumped by 179.54% to -$8347.3 in 2021.
- Business Quant data shows GRUSF's Non-Current Deffered Revenue at -$8347.3 in Q4 2021, $10494.0 in Q4 2020, and $19690.0 in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Grown Rogue International | 116.22 Mn | 104.68 Mn | 5.37 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2021 | -8,347.32 |
| Oct 31, 2020 | 10,494.00 |
| Jul 31, 2020 | 19,690.00 |
| Apr 30, 2020 | 29,400.00 |
| Jan 31, 2020 | 34,238.00 |
| Oct 31, 2019 | 24,505.00 |
| Jul 31, 2019 | 25,819.00 |
| Apr 30, 2019 | 27,131.00 |
| Jan 31, 2019 | 28,444.00 |
| Oct 31, 2018 | 31,256.00 |
| Apr 30, 2018 | 36,881.00 |
| Oct 31, 2017 | 24,912.00 |